X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
humans (6) 6
cancer (5) 5
oncology (5) 5
female (4) 4
male (4) 4
patient outcomes (4) 4
aged (3) 3
bevacizumab (3) 3
clear cell-type renal cell carcinoma (3) 3
clinical trials (3) 3
medical research (3) 3
metastases (3) 3
middle aged (3) 3
quality of life (3) 3
abridged index medicus (2) 2
aged, 80 and over (2) 2
analysis (2) 2
antibodies, monoclonal - therapeutic use (2) 2
bevacizumab - therapeutic use (2) 2
cancer therapies (2) 2
carcinoma, renal cell (2) 2
carcinoma, renal cell - drug therapy (2) 2
care and treatment (2) 2
cell survival (2) 2
consortia (2) 2
data processing (2) 2
endothelial growth-factor (2) 2
guidelines (2) 2
immunotherapy (2) 2
international standards (2) 2
kidney neoplasms - drug therapy (2) 2
medicine, research & experimental (2) 2
metastasis (2) 2
patients (2) 2
pd-l1 protein (2) 2
qualitative research (2) 2
randomization (2) 2
standards (2) 2
studies (2) 2
sunitinib - therapeutic use (2) 2
treatment outcome (2) 2
vascular endothelial growth factor (2) 2
1st-line treatment (1) 1
act assessment (1) 1
activities of daily living (1) 1
adult (1) 1
allergy (1) 1
allergy and immunology (1) 1
alzheimer disease - psychology (1) 1
alzheimer's disease (1) 1
alzheimers-disease (1) 1
angiogenesis (1) 1
angiogenesis inhibitors (1) 1
anthracycline-pretreated patients (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - pharmacology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
aromatase inhibitor (1) 1
association (1) 1
asthma (1) 1
asthma - physiopathology (1) 1
asthma - therapy (1) 1
bevacizumab - adverse effects (1) 1
bevacizumab - pharmacology (1) 1
biochemistry & molecular biology (1) 1
bioindicators (1) 1
biomarkers (1) 1
breast cancer (1) 1
breast-cancer (1) 1
cancer clinical trials (1) 1
cancer patients (1) 1
capecitabine plus docetaxel (1) 1
carcinoma, renal cell - genetics (1) 1
carcinoma, renal cell - mortality (1) 1
carcinoma, renal cell - secondary (1) 1
care (1) 1
cell biology (1) 1
child (1) 1
child, preschool (1) 1
children & youth (1) 1
clinical neurology (1) 1
clinical trials as topic (1) 1
clinical-trials (1) 1
cognition (1) 1
cognitive dysfunction - psychology (1) 1
comparative analysis (1) 1
confidence intervals (1) 1
control (1) 1
critical path institute (1) 1
decision-making (1) 1
dementia (1) 1
development and progression (1) 1
diagnosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 06/2018, Volume 24, Issue 6, pp. 749 - 757
We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib... 
MEDICINE, RESEARCH & EXPERIMENTAL | MULTICENTER | PD-L1 EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHASE-III | SINGLE-ARM | CANCER | CELL BIOLOGY | PATHWAY | SUPPRESSOR-CELLS | NIVOLUMAB | TUMOR-GROWTH | ENDOTHELIAL GROWTH-FACTOR | Sunitinib - pharmacology | Bevacizumab - pharmacology | Kidney Neoplasms - genetics | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Renal Cell - genetics | Antibodies, Monoclonal - therapeutic use | Male | Gene Expression Profiling | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Aged, 80 and over | Adult | Female | Carcinoma, Renal Cell - drug therapy | Antibodies, Monoclonal - pharmacology | Kaplan-Meier Estimate | Treatment Outcome | Mutation - genetics | Sunitinib - adverse effects | Sunitinib - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Kidney Neoplasms - drug therapy | Development and progression | Dosage and administration | Angiogenesis inhibitors | Carcinoma, Renal cell | Comparative analysis | Drug therapy | Cell survival | Inflammation | Gene expression | Molecular chains | Bevacizumab | Metastases | Confidence intervals | Angiogenesis | Immune checkpoint | Immunotherapy | γ-Interferon | PD-L1 protein | Biomarkers | Bioindicators | Vascular endothelial growth factor | Clear cell-type renal cell carcinoma | Index Medicus
Journal Article
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10189, pp. 2404 - 2415
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 10/2015, Volume 33, Issue 28, pp. 84 - 84
Conference Proceeding
Clinical Trials, ISSN 1740-7745, 12/2018, Volume 15, Issue 6, pp. 624 - 630
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18138 - e18138
Conference Proceeding
Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 08/2010, Volume 126, Issue 2, pp. 267 - 273.e1
The Childhood Asthma Control Test (C-ACT) has demonstrated validity in classifying children aged 4 to 11 years as having either "well-controlled" or "not... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. e510 - e514
Summary Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data in cancer randomised trials to assist in... 
Hematology, Oncology and Palliative Medicine | EVEROLIMUS PLUS EXEMESTANE | BREAST-CANCER | ONCOLOGY | Quality of Life | Neoplasms - therapy | Clinical Trials as Topic | Neoplasms - psychology | Humans | Patient Reported Outcome Measures | Clinical trials | Cancer patients | Patient outcomes | Index Medicus
Journal Article
Oncology Nursing Forum, ISSN 0190-535X, 05/2011, Volume 38, Issue 3, pp. E191 - E203
Purpose/Objectives: To systematically review published qualitative reports of descriptions of fatigue by patients with cancer and how cancer-related fatigue... 
ONCOLOGY | NURSING | Nursing Methodology Research | Neoplasms - complications | Neoplasms - nursing | Fatigue - nursing | Humans | Fatigue - etiology | Qualitative Research | Oncology Nursing - methods | Fatigue | Care and treatment | Patient outcomes | Risk factors | Methods | Cancer | Index Medicus | Nursing
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.